The FDA's Peptide Crackdown: A Complete Timeline
Timeline of FDA enforcement actions against peptide vendors from 2023-2026: warning letters, criminal cases, and regulatory changes.
Evidence: well established
Independent Peptide Analysis
We don't sell peptides.
We tell you the truth about them.
Evidence-based analysis, vendor accountability, and honest guidance in a market flooded with marketing claims. No vendor sponsorship. No pay-for-play reviews.
Latest Intelligence
View all analysis →What's Actually in Your Peptides? The Quality Crisis Nobody Talks About
Analysis of independent testing data revealing alarming quality failures in grey-market peptides. What Finnrick, Janoshik, and other labs have found.
Evidence: expert analysis
Infiniwell Review: When Marketing Outruns the Science
Independent deep dive into Infiniwell's SNAC-enhanced BPC-157 products. We examine the technology claims, the missing studies, and what consumers should know.
Evidence: expert analysis
PDA vs. BPC-157: The Same Peptide in a Different Wrapper
Analysis of Pentadeca Arginate (PDA) claims: the patent, the chemistry, and the missing evidence behind '99% bioavailability' marketing.
Evidence: expert analysis
The Semaglutide Crisis: When the Only Proven Peptide Becomes the Most Dangerous
How semaglutide went from pharmaceutical breakthrough to public health crisis. The compounding controversy, counterfeit risks, and what consumers need to know.
Evidence: well established
TB-500 Is Not Thymosin Beta-4: The Fragment Problem
Critical analysis of TB-500 vs. Thymosin Beta-4. The research uses one molecule; the market sells another. We examine what the evidence actually supports.
Evidence: expert analysis
Vendor Report Card
Oral BPC-157 vendors rated on transparency, third-party testing, value, and regulatory compliance. Updated quarterly.
A-
Science.bio (Closed)
View full report → Transparency 95
Testing 90
Value 70
Compliance 40
B+
Peptide Partners
View full report → Transparency 80
Testing 90
Value 55
Compliance 65
B
Eternal Peptides
View full report → Transparency 70
Testing 80
Value 55
Compliance 60
B
Verified Peptides
View full report → Transparency 75
Testing 75
Value 55
Compliance 60
Ratings reflect our independent analysis. Vendors cannot pay to improve their scores. See our methodology.
Peptide Knowledge Base
Evidence-rated profiles for every major peptide. What the research shows, what it doesn't, and what vendors won't tell you.
Stay Informed. Stay Independent.
Weekly analysis of the peptide market: regulatory changes, vendor evaluations, research updates, and the news that matters. Zero vendor influence.